IDX-184 is a superior HCV direct-acting antiviral drug: A QSAR study
Citation:
Elfiky, A. A., and W. M. Elshemey,
"IDX-184 is a superior HCV direct-acting antiviral drug: A QSAR study",
Medicinal Chemistry Research, vol. 25, issue 5, pp. 1005 - 1008, 2016.